Oculocutaneous Albinism (Ocular Albinism)

Key Points at a Glance

Key Points of This Disease

• This is a group of hereditary diseases characterized by congenital reduction in melanin production, leading to pigment deficiency in the eyes, skin, and hair.
• There are two main types: oculocutaneous albinism (OCA, autosomal recessive inheritance) and ocular albinism (OA, X-linked recessive inheritance).
• Representative types include OCA1–4 (TYR, OCA2, TYRP1, SLC45A2 genes) and OA1 (GPR143 gene).
• The three main symptoms are nystagmus, photophobia, and reduced visual acuity, accompanied by albinotic fundus and foveal hypoplasia (absence of foveal depression).
• There is no curative treatment; management focuses on refractive correction, amblyopia therapy, tinted glasses, and low vision care.
• Although non-progressive, visual prognosis varies by type, and nystagmus tends to decrease with growth.

1. What is oculocutaneous albinism (ocular albinism)?

Oculocutaneous albinism (OCA) and ocular albinism (OA) are a group of hereditary disorders characterized by congenital hypopigmentation due to reduced melanin production. Melanin is produced through the melanin synthesis pathway, where tyrosinase is the rate-limiting enzyme, and mutations in genes involved in this pathway cause pigment deficiency.

OCA involves hypopigmentation of the skin, hair, and eyes and follows autosomal recessive inheritance. Currently, four main types (OCA1–4) are known, each caused by mutations in different genes.

OA is a form in which symptoms are limited to the eyes and follows X-linked recessive inheritance. It predominantly affects males, while female carriers are asymptomatic or may show only mosaic fundus findings. OA type 1 is caused by abnormalities in the GPR143 gene and is characterized by abnormal melanosome formation.

Both types present with nystagmus, photophobia, and reduced visual acuity due to ocular pigment deficiency. Foveal hypoplasia is a common key finding, and the absence of a foveal pit on OCT provides diagnostic evidence.

2. Classification

The classification of oculocutaneous albinism and ocular albinism is shown below.

Type	Causative gene	Inheritance pattern	Main features
OCA1	TYR (tyrosinase)	Autosomal recessive	Most severe type. Marked lack of pigment in skin and hair.
OCA2	OCA2	Autosomal recessive	Most common type. Moderate degree of hypopigmentation
OCA3	TYRP1 (tyrosinase-related protein 1)	Autosomal recessive	Common in people of African descent
OCA4	SLC45A2 (melanosome membrane transporter)	Autosomal recessive	More common in Asian populations
OA1	GPR143 (G protein-coupled receptor)	X-linked recessive	Limited to the eyes. More common in males; female carriers have mosaic fundus

OCA1 presents the most severe pigment deficiency due to complete absence or marked reduction of tyrosinase activity. OCA2 is caused by dysfunction of the OCA2 protein (involved in melanosome pH regulation) and is the most common type of OCA. OCA4 results from mutations in SLC45A2 (a melanosome membrane transporter) and is frequently reported in East Asian populations.

Syndromic Albinism

Syndromic albinism, in which reduced melanin production appears as part of a systemic disease, is also known.

Caution for Syndromic Albinism

Chédiak-Higashi syndrome is associated with immunodeficiency. It may cause susceptibility to infections, recurrent fever, and bleeding tendency. Hermansky-Pudlak syndrome is associated with bleeding tendency (platelet dysfunction). Since these syndromes have systemic complications affecting life prognosis, definitive diagnosis is important.

3. Main Symptoms and Clinical Findings

Subjective Symptoms

The three main symptoms of albinism are nystagmus, photophobia, and reduced visual acuity. Nystagmus is often horizontal pendular nystagmus, observed from early infancy. Photophobia reflects the reduced light-blocking function due to melanin deficiency, causing severe discomfort outdoors. Reduced visual acuity is primarily due to foveal hypoplasia, with corrected visual acuity ranging from 0.1 to 0.5.

Fundus Findings

The albinotic fundus is a characteristic finding of this disease, where choroidal vessels are visible due to melanin deficiency in the retinal pigment epithelium (RPE).

In OCA, depigmentation of the fundus is prominent, and iris translucency is increased. When light is shone on the iris during examination, a red reflex is visible, making the iris appear translucent. In OA, retinal depigmentation is relatively mild.

Both types are accompanied by foveal hypoplasia. OCT shows absence of the foveal pit and flattening of the retinal structure at the fovea. Fluorescein angiography shows disappearance or reduction of the foveal avascular zone (FAZ). These findings are important for objective evaluation of foveal hypoplasia.

ERG and Electrophysiology

ERG is normal in X-linked recessive inheritance (OA1). Some cases present with high myopia and findings resembling incomplete congenital stationary night blindness (CSNB-like), but the inheritance pattern is unknown.

Carrier Findings (OA1 Type)

In OA1 type (X-linked recessive), characteristic findings appear in the fundus of carrier mothers. Patchy depigmented spots (mosaic fundus) are seen in the peripheral retina, due to uneven X-chromosome inactivation (lyonization) causing a mosaic mixture of pigmented and non-pigmented cells. In diagnosing OA1, confirming the mosaic fundus in the mother is a strong clue for family diagnosis.

4. Causes and Risk Factors

Abnormalities in Melanin Synthesis Pathway

Melanin production occurs in melanosomes within melanocytes. The amino acid tyrosine is oxidized by tyrosinase (TYR) to form DOPA, which is then converted to dopaquinone. From dopaquinone, eumelanin (black-brown, high photoprotective function) or pheomelanin (red-yellow) is produced.

The molecular mechanisms of each type are as follows.

• OCA1 (TYR mutation): Deficiency (OCA1a: complete loss) or reduction (OCA1b: temperature-sensitive) of tyrosinase activity leads to complete or severe loss of melanin production.
• OCA2 (OCA2 mutation): The OCA2 protein regulates melanosomal pH (chloride ion transport). pH dysregulation indirectly inactivates tyrosinase, reducing melanin production.
• OCA3 (TYRP1 mutation): TYRP1 (tyrosinase-related protein 1) is involved in the later stages of melanin synthesis. Loss of function reduces melanin production.
• OCA4 (SLC45A2 mutation): Loss of function of SLC45A2 (a melanosomal membrane transporter) impairs substrate supply to melanosomes.
• OA1 (GPR143 mutation): Loss of function of GPR143 (a G protein-coupled receptor on melanosomes) causes abnormal enlargement of melanosomes (macromelanosomes), impairing normal pigment production and distribution.

Inheritance and Risk

OCA (OCA1–4) is inherited in an autosomal recessive pattern. If both parents are carriers (heterozygotes), there is a 1 in 4 (25%) chance that a child will be affected.

OA1 is inherited in an X-linked recessive pattern. If a male child inherits the mutation from a carrier mother, there is a 1 in 2 (50%) chance of being affected. Females are typically asymptomatic carriers but may exhibit the aforementioned mosaic fundus.

Abnormal Decussation of Nerve Fibers at the Optic Chiasm

Normally, nerve fibers from the temporal retina project to the ipsilateral lateral geniculate nucleus (LGN), while only fibers from the nasal retina cross at the optic chiasm. In albinism, chiasmal misrouting occurs, causing an excessive crossing of temporal retinal fibers to the contralateral side. This abnormality leads to impaired stereopsis and can be detected as a crossed asymmetry pattern on visual evoked potentials (VEP).

5. Diagnosis and Examination Methods

Key Points in Clinical Diagnosis

Clinical diagnosis is easy when the four findings—albinotic fundus, nystagmus, photophobia, and iris transillumination—are all present. In particular, the albinotic fundus is a highly specific finding for this disease and is useful for differentiation from other diseases. It is often discovered when infants or young children visit an ophthalmologist for nystagmus or photophobia.

Ophthalmic Examinations

• OCT (Optical Coherence Tomography): Confirms the absence of the foveal pit. This is an essential test for objective evaluation of macular hypoplasia, and the absence of the pit provides a basis for diagnosis.
• Fluorescein Angiography (FA): Confirms the absence or reduction of the foveal avascular zone (FAZ). Useful for assessing the degree of macular hypoplasia.
• ERG (electroretinogram): Normal in OA1 type. Used to differentiate from the incomplete CSNB-like type.
• VEP (visual evoked potential): Used to detect chiasmal misrouting. Normally, responses from each eye are symmetric over the contralateral occipital area, but in albinism, crossed asymmetry (temporal stimulation dominant on the contralateral side) is characteristic.

Key points for carrier diagnosis

When examining a male child suspected of having OA1 type (X-linked recessive inheritance), always check the mother’s fundus. Carrier mothers often show depigmented spots (mosaic fundus) in the peripheral retina, which is a key finding for carrier diagnosis. Identifying a carrier allows genetic counseling to accurately convey the risk of disease to future siblings.

Genetic testing

Search for causative genes of OCA1-4 and OA1 (GPR143). Gene panel testing or whole exome sequencing is used. Determining the genotype is useful for definitive diagnosis, genetic counseling, and prognosis prediction (OCA1 is the most severe).

Differential Diagnosis

Waardenburg syndrome is an important differential diagnosis. Waardenburg syndrome is an autosomal dominant disorder characterized by iris heterochromia, systemic pigmentary abnormalities, and hearing loss, caused by mutations in PAX3 or MITF genes. The fundus may show mild depigmentation, but unlike albinism, foveal hypoplasia is absent. The presence or absence of hearing loss and the type of iris heterochromia are key to differentiation.

6. Standard Treatment

There is no curative treatment. Management focuses on symptomatic treatment for individual symptoms and complications, along with low vision care.

Refractive Correction and Amblyopia Treatment

Refractive correction is the most important therapeutic intervention for amblyopia treatment. Early correction of myopia and astigmatism promotes visual development. Prescribe glasses from infancy and perform regular refraction examinations.

If anisometropia is present, amblyopia training is performed by occluding the healthy eye. Appropriate refractive correction and amblyopia treatment during childhood directly maximize residual visual acuity.

Tinted Glasses (Photophobia Management)

Due to the lack of melanin’s light-blocking function, severe photophobia persists. Tinted glasses (light-filtering lenses) reduce photophobia and improve visual quality. They are also effective for protection against ultraviolet rays and bright light outdoors. Lens color should be selected according to individual symptoms, and it is desirable to start use from childhood.

Management of Nystagmus

Surgical intervention (extraocular muscle surgery) for nystagmus is not common. If abnormal head posture is prominent, prism glasses may be used to improve head position. The impact of nystagmus on visual acuity varies by case, but nystagmus tends to become less noticeable with growth.

Low Vision Care

Since the visual impairment caused by this disease is difficult to cure, low vision care that maximizes the use of remaining vision is important.

• Optical aids: Magnifying glasses (monoculars, binoculars, low vision glasses), magnifying reading devices
• Non-optical aids: Large-print textbooks and handouts, book stands, tablet devices
• Optimizing lighting environment: Ensure necessary illumination while avoiding glare
• School support: Seating arrangement (closer to the blackboard), enlarged teaching materials, use of tablet devices

During school age, the arrangement of the educational environment (seating, enlarged materials) is essential for learning support. Collaboration with specialized visual rehabilitation facilities is desirable.

Skin Management (for OCA)

In OCA, the lack of melanin in the skin reduces protection against ultraviolet radiation. Strict UV protection (sunscreen with SPF 30 or higher, hats, long sleeves, use of parasols) is essential. Long-term risk of skin cancer (basal cell carcinoma, squamous cell carcinoma) is increased, so regular follow-up with a dermatologist is important.

Genetic Counseling

Both OCA (autosomal recessive) and OA1 (X-linked recessive) are hereditary disorders, making genetic counseling for families important. Accurately communicate recurrence risks according to the inheritance pattern and explain the significance of carrier testing (especially for mothers in OA1).

7. Pathophysiology and Detailed Mechanisms

Molecular Mechanisms of Each Type

Melanin synthesis occurs in melanosomes within melanocytes. Tyrosinase acts as the rate-limiting enzyme in the process from tyrosine → DOPA → dopaquinone → eumelanin (black-brown) or pheomelanin (red-yellow).

The molecular characteristics of each type are shown below.

• OCA1: Melanin production is almost completely absent due to a deficiency (OCA1a) or marked reduction (OCA1b: temperature-sensitive mutation) of tyrosinase (TYR) activity. This is the most severe type among all forms.
• OCA2: Loss of function of the OCA2 protein (a melanosomal membrane protein involved in chloride ion transport) leads to an increase in melanosomal pH, indirectly inactivating tyrosinase.
• OCA3: Loss of function of TYRP1 (tyrosinase-related protein 1) specifically impairs eumelanin production.
• OCA4: Loss of function of SLC45A2 (a melanosomal membrane transporter) impairs substrate supply to melanosomes. This type is frequent in East Asian populations.
• OA1: Loss of function of GPR143 (G protein-coupled receptor on melanosomes) causes melanosomes to become enlarged (macromelanosomes), impairing pigment production and distribution.

Mechanism of foveal hypoplasia

During fetal development, normal differentiation of the fovea requires melanin signals from the retinal pigment epithelium (RPE). When melanin deficiency disrupts this signal, the migration and accumulation of cone cells in the fovea are incomplete, and the foveal pit does not form (foveal hypoplasia). This developmental abnormality cannot be corrected after birth, making foveal hypoplasia a permanent finding.

Pigment deficiency in the retinal pigment epithelium and light scattering

Normal RPE melanin absorbs incident light, preventing light scattering and enhancing visual quality. In albinism, RPE melanin is deficient, leading to increased intraocular light scattering, reduced contrast sensitivity, and visual impairment.

Chiasmal misrouting

Normally, nerve fibers from the nasal half of the retina cross to the opposite side at the optic chiasm, while fibers from the temporal half project to the same side (uncrossed). In albinism, this segregation becomes abnormal, and even the temporal fibers, which should remain uncrossed, excessively cross to the opposite side (chiasmal misrouting).

This abnormality disrupts the balance of input from the right and left eyes to the contralateral cerebral hemispheres, impairing the formation of binocular stereopsis. On VEP, it appears as “crossed asymmetry,” where a large positive wave is recorded over the contralateral occipital region that should not normally respond to monocular stimulation. This finding is characteristic for the electrophysiological diagnosis of this disease.

8. Prognosis and Course

Both oculocutaneous albinism and ocular albinism are non-progressive diseases. Symptoms do not worsen with age and follow a relatively stable course.

The severity of visual impairment varies greatly by type. OCA1 is the most severe and is considered to have the poorest visual prognosis among albinism types. OCA2, 3, 4, and OA1 are often relatively mild. Corrected visual acuity ranges from about 0.1 to 0.5, and the degree of foveal hypoplasia is the main determinant of visual prognosis.

Nystagmus tends to become less noticeable with growth. This is thought to be due to the development of fixation ability and compensatory adaptation, and the reduction of nystagmus may contribute to visual improvement.

Long-term low vision care is essential for maintaining visual function and improving quality of life. Support tailored to each life stage is required, such as optimizing the learning environment during school age and providing vocational training and employment support from adolescence onward.

In syndromic albinism (Chédiak-Higashi syndrome, Hermansky-Pudlak syndrome), attention must also be paid to the prognosis of systemic complications (immunodeficiency, bleeding tendency) in addition to ocular findings. In OCA, the lack of melanin in the skin significantly reduces protection against ultraviolet radiation, leading to an increased long-term risk of skin cancer (basal cell carcinoma, squamous cell carcinoma).

Q How much can vision improve in children with albinism?

A

Corrected visual acuity ranges from about 0.1 to 0.5 depending on the degree of foveal hypoplasia. Although there is no curative treatment, residual vision can be maximized through appropriate refractive correction and low vision care. Nystagmus tends to decrease with growth, which may lead to improvement in visual function.

Q How are ocular albinism (OA) and oculocutaneous albinism (OCA) differentiated?

A

OCA involves widespread hypopigmentation of the skin, hair, and eyes, whereas OA is limited to the eyes. OA is X-linked recessive, and mosaic depigmented patches in the peripheral fundus of the mother can be a clue for carrier diagnosis. Genetic testing (GPR143 gene) can confirm the diagnosis.

Q What should be noted in daily life for albinism?

A

Regular use of light-blocking glasses (for photophobia), UV protection (sunscreen, hats, long sleeves), and optimization of indoor lighting are important. For low vision care, magnifiers and video magnifiers are also useful. During school age, adjustments to the educational environment (seating arrangement, enlarged teaching materials) are necessary for learning support. For the skin, daily self-checks and regular dermatology visits are important for long-term prevention of skin cancer.

References

1. Grønskov K, Ek J, Brondum-Nielsen K. Oculocutaneous albinism. Orphanet J Rare Dis. 2007;2:43. doi:10.1186/1750-1172-2-43. PMID: 17980020
2. Thomas MG, Zippin J, Brooks BP. Oculocutaneous Albinism and Ocular Albinism Overview. In: GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 2023. NBK ID: NBK590568
3. Neveu MM, Padhy SK, Ramamurthy S, et al. Ophthalmological Manifestations of Oculocutaneous and Ocular Albinism: Current Perspectives. Clin Ophthalmol. 2022;16:1569-1587. doi:10.2147/OPTH.S329282. PMID: 35637898
4. Thomas MG, Kumar A, Mohammad S, et al. Structural Grading of Foveal Hypoplasia Using Spectral Domain Optical Coherence Tomography; A Predictor of Visual Acuity? Ophthalmology. 2011;118(8):1653-1660. doi:10.1016/j.ophtha.2011.01.028. PMID: 21529956
5. Introne WJ, Huizing M, Malicdan MCV, O’Brien KJ, Gahl WA. Hermansky-Pudlak Syndrome. In: GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 2000 [updated 2023]. NBK ID: NBK1287